96 related articles for article (PubMed ID: 1768374)
1. Intratumoral tumor necrosis factor induction in tumor-bearing mice by exogenous/endogenous tumor necrosis factor therapy as compared with systemic administration of various biologic response modifiers.
Nishizawa T; Okutomi T; Inagawa H; Morikawa A; Oshima H; Soma G; Mizuno D
Mol Biother; 1991 Dec; 3(4):224-30. PubMed ID: 1768374
[TBL] [Abstract][Full Text] [Related]
2. [Induction of tumor necrosis factor (TNF) in tumor-bearing mice].
Tamura K; Ishida N
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1369-78. PubMed ID: 6378101
[TBL] [Abstract][Full Text] [Related]
3. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
Inagawa H; Nishizawa T; Honda T; Nakamoto T; Takagi K; Soma G
Anticancer Res; 1998; 18(5D):3957-64. PubMed ID: 9854510
[TBL] [Abstract][Full Text] [Related]
5. Molecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation.
Tsutsumi Y; Kihira T; Tsunoda S; Kamada H; Nakagawa S; Kaneda Y; Kanamori T; Mayumi T
J Pharmacol Exp Ther; 1996 Sep; 278(3):1006-11. PubMed ID: 8819479
[TBL] [Abstract][Full Text] [Related]
6. Administration of subtumor regression dosage of TNF-alpha to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule.
Lu Y; Yamauchi N; Koshita Y; Fujiwara H; Sato Y; Fujii S; Takahashi M; Sato T; Kato J; Yamagishi H; Niitsu Y
Gene Ther; 2001 Apr; 8(7):499-507. PubMed ID: 11319616
[TBL] [Abstract][Full Text] [Related]
7. Nociceptive characteristics of tumor necrosis factor-alpha in naive and tumor-bearing mice.
Wacnik PW; Eikmeier LJ; Simone DA; Wilcox GL; Beitz AJ
Neuroscience; 2005; 132(2):479-91. PubMed ID: 15802198
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice.
Kaneda Y; Yamamoto Y; Kamada H; Tsunoda S; Tsutsumi Y; Hirano T; Mayumi T
Cancer Res; 1998 Jan; 58(2):290-5. PubMed ID: 9443407
[TBL] [Abstract][Full Text] [Related]
9. [The mechanism of action of tumor necrosis factor (TNF) on tumor vascularity--study using a transparent chamber].
Watanabe N; Niitsu Y; Umeno H; Kuriyama H; Neda H; Yamauchi N; Maeda M; Urushizaki I
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3337-43. PubMed ID: 3318706
[TBL] [Abstract][Full Text] [Related]
10. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
Inagawa H; Oshima H; Soma G; Mizuno D
J Biol Response Mod; 1988 Dec; 7(6):596-607. PubMed ID: 3216223
[TBL] [Abstract][Full Text] [Related]
11. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
Satoh M; Inagawa H; Shimada Y; Soma G; Oshima H; Mizuno D
J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
[TBL] [Abstract][Full Text] [Related]
12. Genetic radiotherapy overcomes tumor resistance to cytotoxic agents.
Seung LP; Mauceri HJ; Beckett MA; Hallahan DE; Hellman S; Weichselbaum RR
Cancer Res; 1995 Dec; 55(23):5561-5. PubMed ID: 7585635
[TBL] [Abstract][Full Text] [Related]
13. Toxic effect of tumor necrosis factor on tumor vasculature in mice.
Watanabe N; Niitsu Y; Umeno H; Kuriyama H; Neda H; Yamauchi N; Maeda M; Urushizaki I
Cancer Res; 1988 Apr; 48(8):2179-83. PubMed ID: 3349488
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of antitumor effect of endogenously induced tumor necrosis factor by cyclophosphamide.
Inagawa H; Ohshiro S; Nishizawa T; Goto S; Soma G; Mizuno D
Anticancer Res; 1997; 17(1A):55-60. PubMed ID: 9066630
[TBL] [Abstract][Full Text] [Related]
15. Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia.
Catalano MG; Fortunati N; Arena K; Costelli P; Aragno M; Danni O; Boccuzzi G
Int J Oncol; 2003 Aug; 23(2):429-36. PubMed ID: 12851692
[TBL] [Abstract][Full Text] [Related]
16. Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia.
Watanabe N; Niitsu Y; Umeno H; Sone H; Neda H; Yamauchi N; Maeda M; Urushizaki I
Cancer Res; 1988 Feb; 48(3):650-3. PubMed ID: 3335027
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the toxicity of tumor necrosis factor by tumors in mice.
Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K
Circ Shock; 1994 Oct; 44(2):77-83. PubMed ID: 7743604
[TBL] [Abstract][Full Text] [Related]
18. Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.
Okutomi T; Inagawa H; Nishizawa T; Oshima H; Soma G; Mizuno D
J Biol Response Mod; 1990 Dec; 9(6):564-9. PubMed ID: 2074443
[TBL] [Abstract][Full Text] [Related]
19. Importance of TNF production for the curative effectiveness of low dose melphalan therapy for mice bearing a large MOPC-315 tumor.
Gorelik L; Rubin M; Prokhorova A; Mokyr MB
J Immunol; 1995 Apr; 154(8):3941-51. PubMed ID: 7706732
[TBL] [Abstract][Full Text] [Related]
20. Protection of zinc against tumor necrosis factor induced lethal inflammation depends on heat shock protein 70 and allows safe antitumor therapy.
Van Molle W; Van Roy M; Van Bogaert T; Dejager L; Van Lint P; Vanlaere I; Sekikawa K; Kollias G; Libert C
Cancer Res; 2007 Aug; 67(15):7301-7. PubMed ID: 17671199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
